Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing
Parasitic helminths infect over 1 billion people worldwide, while current treatments rely on a limited arsenal of drugs. To expedite drug discovery, we screened a small-molecule library of compounds with histories of use in human clinical trials for anthelmintic activity against the soil nematode Ca...
Saved in:
Published in | Scientific reports Vol. 8; no. 1; pp. 975 - 17 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
17.01.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Parasitic helminths infect over 1 billion people worldwide, while current treatments rely on a limited arsenal of drugs. To expedite drug discovery, we screened a small-molecule library of compounds with histories of use in human clinical trials for anthelmintic activity against the soil nematode
Caenorhabditis elegans
. From this screen, we found that the neuromodulatory drugs sertraline, paroxetine, and chlorpromazine kill
C. elegans
at multiple life stages including embryos, developing larvae and gravid adults. These drugs act rapidly to inhibit
C. elegans
feeding within minutes of exposure. Sertraline, paroxetine, and chlorpromazine also decrease motility of adult
Trichuris muris
whipworms, prevent hatching and development of
Ancylostoma caninum
hookworms and kill
Schistosoma mansoni
flatworms, three widely divergent parasitic helminth species.
C. elegans
mutants with resistance to known anthelmintic drugs such as ivermectin are equally or more susceptible to these three drugs, suggesting that they may act on novel targets to kill worms. Sertraline, paroxetine, and chlorpromazine have long histories of use clinically as antidepressant or antipsychotic medicines. They may represent new classes of anthelmintic drug that could be used in combination with existing front-line drugs to boost effectiveness of anti-parasite treatment as well as offset the development of parasite drug resistance. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-18457-w |